Kyowa Kirin Co., Ltd.

This early-stage study is testing the safety of a new drug called KK3910 for high blood pressure. Researchers will give single doses to healthy volunteers and multiple doses to people with hypertension to check for side effects. The study will also measure how the drug moves thro…

This is the first study in people for a new drug called KK2269. It aims to find a safe dose and see how well the body tolerates it. The study will test KK2269 alone in people with various advanced solid tumors, and also test it combined with a standard chemotherapy drug (docetaxe…

This is the first time a new drug called KK2845 is being tested in people. The study aims to find a safe and tolerable dose for adults with acute myeloid leukemia (AML) that has returned after treatment or has not responded to standard therapies. Researchers will monitor patients…

This is the first study in people to test an experimental drug called KK8123, given as an injection under the skin. It aims to find a safe and tolerable dose for adults with X-linked hypophosphatemia (XLH), a rare genetic disorder that causes weak bones and low phosphate levels. …

This is the first time researchers are testing the experimental drug KK2260 in people. The study aims to find a safe dose for patients with advanced solid tumors that have spread. Later parts will test if the drug can help control specific cancers of the esophagus, head, and neck…

This study is monitoring how safe and effective the drug Poteligeo (mogamulizumab) is for patients in Korea who are already using it to treat two rare types of skin lymphoma. It will follow about 15 adult patients who have tried at least one other treatment before. The goal is to…